PMID: 2510771Jun 1, 1989Paper

Thrombolytic therapy: a review of the literature on streptokinase and tissue plasminogen activator with implications for practice

Critical Care Nursing Clinics of North America
C Brewer-Senerchia

Abstract

Thrombolytic therapy has had a major impact on the outcome of AMI patients. For the first time, medicine has a means of interrupting the process of myocardial necrosis and limiting the potential size of the infarction. For those patients who can receive thrombolytic therapy and who seek medical attention within the first few hours of infarction, the impact of successful thrombolysis on ventricular function is most substantial. Also, in some patients with continuing symptoms, benefit may be seen beyond the 3- to 6-hour time limit. However, the therapy is not yet perfect. No thrombolytic agent has consistently been able to attain reperfusion in more than 75 per cent of those treated. There are significant bleeding risks associated with these medications, and the best adjunctive therapy to prevent reocclusion has not been established. Nursing has also been significantly affected by the addition of thrombolysis to the coronary care and emergency units. The role of identifying appropriate patients, caring for the patient during thrombolysis, and dealing with complications of the therapy has added a new dimension to the nursing care of the infarction patient. In the era of nursing shortages, these additional tasks may be difficult to...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.